Abiopharma

🔍 Yang Watkin Phoebe L. (Director)

Company: Doximity, Inc. (DOCS)

Report Date: 2025-08-28

Detailed Transactions and Holdings:

• Acquired 3,221 shares of Class A Common Stock (Direct)
  Date: 2025-08-28 | Code: A | equity_swap_involved: 0 | shares_owned_after: 17,950.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: These shares represent restricted stock units (each, an "RSU") granted on August 28, 2025 pursuant to the Issuer's non-employee director compensation policy, which vest in full on the earlier of (i) the first anniversary of the grant date or (ii) the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service as a director through the applicable vesting date. Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock.